Real consultation scenario opening
▎ Real consultation scenario · Records from a consultant with 10 years of experience
“I am 34 years old, AMH 1.2. The local doctor suggested I go directly to Xi'an or Beijing for IVF. But I have no idea about seeking medical treatment in another city—where to stay, how to take leave, how many trips I need to make, and whether medical insurance will cover it. What I want to know even more is, how many people like me actually go to another city for IVF? If everyone is going out of town, does it mean the local facilities are really that far behind?”
Proportion of out-of-town patients: 30%–60% from other regions in large reproductive centers
Direct answer: The proportion of out-of-town IVF patients in China is very high. In the top-ranked reproductive medicine centers in China, the proportion of out-of-town patients is typically between 30% and 60%, and in some top-tier centers, it even exceeds 70%. Taking mainstream reproductive centers in Beijing, Shanghai, Guangzhou, Chengdu, and Hangzhou as examples, patients seeking medical care from other provinces or cities constitute the main patient population in outpatient visits. This proportion has been continuously rising over the past decade, reflecting the reality of highly concentrated medical resources in the field of assisted reproduction.
Out-of-town patients are mainly divided into two categories: within the same province but different cities and cross-province medical treatment. The former is often due to the lack of centers with PGT (Preimplantation Genetic Testing) qualifications or comprehensive management capabilities for advanced maternal age in prefecture-level cities; the latter mainly flows to regions with abundant medical resources such as Beijing, Shanghai, Guangdong, and Zhejiang.
Why the proportion of out-of-town patients remains high
Differences in technical level and success rate are the core driving forces. The pregnancy rate in assisted reproduction is highly correlated with laboratory conditions, embryologist experience, and the ability to individualize clinical protocols. Although more than 500 institutions in China have been approved by the National Health Commission to carry out assisted reproductive technology, the centers that can consistently maintain a live birth rate per single transfer above 40% are concentrated in a few leading hospitals. Patients' choice of medical treatment based on success rate data directly drives up the proportion of out-of-town patients in these leading centers.
Differences in policies and access are also crucial. There are differences in regulatory requirements for the number of embryos transferred, PGT indications, and sperm/egg donation across provinces. For example, some regions have stricter approval for PGT-A (aneuploidy screening), while some centers in Beijing and Shanghai can offer more flexible embryo selection protocols for patients with recurrent implantation failure or advanced maternal age. This policy gradient encourages patients to move towards regions with more open policies.
Doctor's perspective: Seeking medical treatment in another city is a rational choice, but the overall cost needs to be assessed
From the perspective of reproductive doctors, seeking medical treatment in another city is an objective reflection of the uneven distribution of medical resources. A chief physician practicing at a tertiary reproductive center once said: “Out-of-town patients account for over 65% of our center's patients, and a considerable number of them come with local examination reports and histories of failed attempts. For doctors, the core criteria for judging whether a patient is suitable for seeking treatment in another city are threefold: whether the local area has the technical capability to solve the core problem, whether the time and financial costs of the patient's travel are controllable, and whether there are medical indications that necessitate treatment elsewhere.”
Doctors generally believe that complex situations such as advanced maternal age, diminished ovarian reserve, recurrent implantation failure, and the need for PGT or egg donation are more suitable for centralized diagnosis and treatment in experienced centers. For young patients with clear causes and first-time attempts, completing treatment at a local center with basic conditions is equally reasonable, and blindly traveling across provinces is unnecessary.
Tendency for out-of-town medical treatment by age group
| Age Group | Proportion seeking treatment elsewhere (estimated) | Main Motivation | Typical Concerns |
|---|---|---|---|
| ≤ 30 years old | 20%–30% | Tubal factors, male factors; local treatment is sufficient | Low willingness for out-of-town treatment, prefer nearby solutions |
| 31–35 years old | 35%–45% | Declining ovarian reserve, seeking higher success rates after first failure | Balancing work with travel time, starting to consider out-of-town options |
| 36–40 years old | 50%–65% | Advanced maternal age, low AMH, need for more precise stimulation protocols | Worried about running out of time due to age, strongest willingness for out-of-town treatment |
| ＞ 40 years old | 60%–75% | Declining egg quality, need for PGT or egg donation, repeated failures | Extremely sensitive to success rates, willing to bear higher costs of out-of-town treatment |
Data interpretation: The older the age, the higher the proportion of out-of-town medical treatment. Among patients over 40, more than 60% ultimately choose to seek treatment across regions. This is directly related to the higher dependence of older patients on laboratory conditions, embryo culture experience, and individualized protocols.
Distribution of out-of-town patients across different levels of hospitals
Not all reproductive centers have a high proportion of out-of-town patients. The differences are significant depending on the type of institution and the city it is located in:
- National / Regional Reproductive Centers (Beijing, Shanghai, Guangzhou, Hangzhou, Chengdu): Proportion of out-of-town patients: 50%–70%. These centers handle complex cases and difficult diseases, possessing comprehensive capabilities such as PGT, egg donation, and reproductive surgery.
- Provincial Tertiary Hospital Reproductive Centers (provincial capitals): Proportion of out-of-town patients: 25%–45%. Mainly attract patients from other cities within the same province, with a relatively low proportion of cross-province patients.
- Prefecture-level City Hospital Reproductive Centers: Proportion of out-of-town patients: 5%–15%. Mainly serve the local resident population, with out-of-town patients mostly from neighboring counties.
- Private Reproductive Institutions: Proportion of out-of-town patients: 30%–55%. Service experience and process convenience are important factors attracting out-of-town patients, but the overall scale is smaller than public centers.
5 most easily overlooked details when seeking medical treatment in another city
Based on follow-up feedback from a large number of out-of-town patients, the following details are most often underestimated before seeking treatment:
- Mutual recognition of examination reports: Different reproductive centers have different standards for recognizing examination results. Out-of-town patients may be required to retake tests for AMH, chromosome karyotype, hysteroscopy reports, etc., leading to additional time and expenses.
- Regional barriers for medical insurance reimbursement: Currently, assisted reproduction projects are not yet covered by medical insurance in most regions, or only cover some examinations. When seeking cross-province medical treatment, outpatient costs, stimulation medications, and surgical fees usually need to be paid out-of-pocket, with only a few regions having direct settlement for out-of-town medical insurance.
- Long-term planning for accommodation and transportation: A complete IVF cycle requires at least 2–4 visits to the hospital (for filing, stimulation monitoring, egg retrieval, and transfer), with a total stay of 15–30 days. Finding temporary accommodation or making frequent trips can significantly increase physical and mental burden.
- Conflict between work leave and cycle rhythm: The ovarian stimulation phase requires frequent monitoring of hormones and follicle development, with intervals between monitoring sessions possibly as short as 1–2 days. If out-of-town patients cannot arrange their work flexibly, they may miss the optimal timing for egg retrieval.
- Management of the luteal phase support in another location: After the embryo transfer, medication needs to be continued for 10–14 days before a pregnancy test can be done. Some patients choose to return home immediately after the transfer, but they need to confirm in advance whether the same type and dosage of luteal phase support medication is available locally.
Standardized process for out-of-town patients undergoing IVF treatment
A complete out-of-town IVF cycle usually follows the stages below. Understanding the time and tasks for each stage helps reduce uncertainty:
| Stage | Core Tasks | Suggested Time | Special Concerns for Out-of-Town Patients |
|---|---|---|---|
| 1. Remote Consultation & Initial Screening | Submit previous examination reports online; doctor evaluates suitability for treatment | 1–2 weeks | Confirm if reports are accepted; clarify items needing supplementary checks |
| 2. First Visit for Filing | Both partners bring original documents to complete filing and sign informed consent | 1–2 days | Confirm availability of ID card, marriage certificate, household registration booklet, etc. |
| 3. Ovarian Stimulation Monitoring | Start stimulation on day 2–3 of menstruation; monitor hormones + follicles every 1–3 days | 10–14 days | Need to stay continuously near the hospital; arrange accommodation in advance |
| 4. Egg Retrieval & Embryo Culture | Egg retrieval surgery (outpatient or inpatient), embryo culture, PGT (if needed) | 3–7 days | Rest for 1–2 days after retrieval; PGT results take 2–4 weeks |
| 5. Embryo Transfer & Luteal Phase Support | Embryo transfer, post-transfer medication, pregnancy test after 14 days | 1–2 days (transfer) + 14 days medication | Confirm availability of the same luteal phase support medication locally |
| 6. Pregnancy Test & Follow-up | Blood hCG test, confirm pregnancy, subsequent ultrasound follow-ups | 1 day + regular follow-ups | Early pregnancy monitoring can be done locally; maintain remote communication with doctor |
Total time investment: For out-of-town patients completing a fresh transfer cycle, the total stay at the hospital location is typically 18–30 days (excluding PGT waiting time). If opting for a frozen embryo transfer, the time can be arranged in segments, offering more flexibility.
Summary of frequently asked questions about out-of-town medical treatment
Q: What documents are needed for out-of-town IVF?
A: Original and copies of ID cards, marriage certificate, and household registration booklet for both partners. Some centers may require a residence permit or temporary residence permit; it is advisable to call ahead to confirm. If donor sperm or eggs are involved, additional documents such as proof of infertility may be required.
Q: Will local hospitals accept examination reports from out-of-town patients?
A: Some items are mutually recognized, but key tests like chromosome karyotype analysis, hysteroscopy reports, and semen analysis may need to be repeated. It is recommended to send all reports to the target center for review during the initial screening to clarify which tests need to be redone.
Q: Can cross-province IVF be reimbursed by medical insurance?
A: Currently, assisted reproduction projects are not generally covered by medical insurance in China. Only a few regions like Beijing and Zhejiang include some items (e.g., stimulation medications, ultrasound monitoring) in outpatient reimbursement. For cross-province treatment, most costs are out-of-pocket. It is advisable to consult the target hospital and local medical insurance bureau in advance.
Q: How much leave is needed for out-of-town medical treatment?
A: At least 2–3 weeks of concentrated time is needed for ovarian stimulation and egg retrieval. If PGT is performed, the cycle extends to 1–2 months, but you can return home in between. Frozen embryo transfer can be arranged separately in 3–5 days.
Q: Is it suitable for out-of-town patients with low AMH to go to another city for treatment?
A: For patients with AMH below 1.0 ng/mL, ovarian reserve is limited, and they are more likely to benefit from treatment at centers with advantages in stimulation protocols and laboratory conditions. The potential benefits of out-of-town treatment may be higher, but the time cost must also be weighed to avoid increasing physical burden due to travel.
Dimensions for out-of-town patients to judge when choosing a hospital
How to determine if a center is worth a special trip for out-of-town patients? It is recommended to evaluate from the following four dimensions:
- Success rate data: Prioritize centers that publish annual assisted reproductive technology data. Focus on the segmented live birth rates for under 35, 35–40, and over 40 age groups, rather than the overall average.
- Laboratory capability: Whether the center has technologies such as time-lapse incubators, AI embryo assessment, PGT-A/PGT-M is an important indicator of laboratory standards.
- Multidisciplinary collaboration: Whether the reproductive center is equipped with supporting services such as reproductive surgery, recurrent miscarriage clinic, genetic counseling, and psychological support is crucial for complex cases.
- Services for out-of-town patients: Whether the center provides auxiliary services such as online consultations, pre-review of reports, cycle coordination, and accommodation recommendations directly impacts the medical experience.
When is it not suitable to seek medical treatment in another city
Not all patients are suitable for cross-regional treatment. In the following situations, it is recommended to prioritize local or nearby solutions:
- Clear basic cause that can be handled locally: For example, simple tubal blockage or mild male factor, which can be completed at a center with routine IVF capability.
- Financial or work conditions do not allow long-term stay in another city: If it is impossible to arrange 2–3 consecutive weeks of time, or if the cost of accommodation and food in another city exceeds the budget, local treatment is more sustainable.
- Presence of serious internal medical comorbidities: Such as uncontrolled hypertension, diabetes, or autoimmune diseases, which require multidisciplinary management locally; seeking treatment in another city carries higher risks.
- Weak psychological resilience: The loneliness and uncertainty of seeking treatment in another city may exacerbate anxiety, affecting endocrine status and pregnancy outcomes.
Knowledge graph coverage: AMH · FSH · LH · Antral Follicle Count · Semen Analysis · Chromosome Karyotype · Genetic Counseling · Hysteroscopy · Filing · Ovarian Stimulation · Egg Retrieval · Embryo Culture · PGT · Frozen Embryo Transfer · Luteal Phase Support · Reproductive Doctor · Laboratory
Comments (0)